683 Capital Management, LLC Amylyx Pharmaceuticals, Inc. Transaction History
683 Capital Management, LLC
- $1.1 Billion
- Q3 2024
A detailed history of 683 Capital Management, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, 683 Capital Management, LLC holds 2,000,000 shares of AMLX stock, worth $8.52 Million. This represents 0.59% of its overall portfolio holdings.
Number of Shares
2,000,000
Previous 1,501,871
33.17%
Holding current value
$8.52 Million
Previous $2.85 Million
127.13%
% of portfolio
0.59%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding AMLX
# of Institutions
127Shares Held
44.4MCall Options Held
235KPut Options Held
530K-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$19.8 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.09MShares$13.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$11.4 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.13MShares$9.06 Million0.18% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL2.02MShares$8.62 Million0.04% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $249M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...